NCT05132790: Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment |
|
|
| Active, not recruiting | N/A | 24 | RoW | SHR-1316 at a dose 20mg/kg q3w, SHR6390 at a dose of 150mg orally, daily, SBRT | Shengjing Hospital, Jiangsu HengRui Medicine Co., Ltd. | Breast Cancer | 12/24 | 12/28 | | |
